A curious pattern in cancer statistics has puzzled scientists for decades. While cancer risk climbs steadily through middle age and beyond, it levels off and even declines among the oldest populations ...

Application supported by Phase 3 data reinforcing teclistamab regimens as a potential standard of care after at least one prior therapy1 ...

Lyell Immunopharma, Inc. ( LYEL) TD Cowen 46th Annual Health Care Conference March 2, 2026 9:10 AM EST ...

aDepartment of Medicine, Division of Hematology, Oncology, and Transplantation, University of Minnesota, Minneapolis, MN, USA bDepartment of Obstetrics, Gynecology ...

Scientists at MIT and Stanford have unveiled a promising new way to help the immune system recognize and attack cancer cells more effectively. Their strategy targets a hidden “off switch” that tumors ...

Polyamines—natural molecules found in every living cell—have become stars in the longevity world for their ability to boost cellular cleanup and support healthy aging. But there’s a dark twist: high ...

Polyamines are naturally produced molecules present in all living cells. They play a vital role in basic biological functions, including cell growth ...

Cancer begins when mutations in specific genes override the body’s built-in controls on cell division, allowing rogue cells ...

Colon cancer is hitting long before the usual screening age. If you could ID who's at risk, you could screen early and save ...

Research has uncovered a surprising biological twist: molecules that help support healthy aging can also contribute to cancer growth.

Inovio Pharmaceuticals, Inc. ( INO) Oppenheimer 36th Annual Healthcare Life Sciences Conference February 25, 2026 12:40 PM EST ...

Scientist Laura Soucek, who removed tumors from rodents almost 20 years ago, invokes the ‘moral duty’ not to generate false expectations after Mariano Barbacid’s announcement ...